ConocoPhillips Total Cost of Revenue increased by 20.9% to $6.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $6.19B to $6.28B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 5.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00B | $4.18B | $6.50B | $6.75B | $9.23B | $9.25B | $8.74B | $6.14B | $4.62B | $5.54B | $5.68B | $5.33B | $4.86B | $4.75B | $5.07B | $6.19B | $5.09B | $5.86B | $5.20B | $6.28B |
| QoQ Change | — | +39.4% | +55.5% | +3.9% | +36.8% | +0.2% | -5.6% | -29.7% | -24.8% | +20.1% | +2.4% | -6.1% | -8.9% | -2.3% | +6.9% | +22.0% | -17.8% | +15.2% | -11.3% | +20.9% |
| YoY Change | — | — | — | — | +208.0% | +121.4% | +34.4% | -9.1% | -50.0% | -40.1% | -35.0% | -13.1% | +5.2% | -14.4% | -10.7% | +16.0% | +4.7% | +23.4% | +2.4% | +1.5% |